Urteste SA
Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, bile ducts, stomach, lung, esophagus, ovary, endometrium, blood, breast, and brain. The company was incorporated in 2021 and is based in Gdansk, Poland.
Urteste SA (URT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.441x
Based on the latest financial reports, Urteste SA (URT) has a cash flow conversion efficiency ratio of 0.441x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł9.55 Million) by net assets (zł21.64 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Urteste SA - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Urteste SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Urteste SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Urteste SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NSN Co. Ltd
KQ:031860
|
-0.027x |
|
Verici Dx plc
PINK:VRCDF
|
-1.497x |
|
Mirae JSC
VN:KMR
|
N/A |
|
Wave Entertainment Public Company Limited
BK:WAVE
|
-0.006x |
|
eEducation Albert AB
ST:ALBERT
|
-0.185x |
|
Tadiran Hldg
TA:TDRN
|
-0.088x |
|
Spackman Equit
V:SQG
|
-0.052x |
|
Golden Heaven Group Holdings Ltd. Ordinary Shares
NASDAQ:GDHG
|
0.020x |
Annual Cash Flow Conversion Efficiency for Urteste SA (2019–2024)
The table below shows the annual cash flow conversion efficiency of Urteste SA from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł24.11 Million | zł-5.47 Million | -0.227x | -18.22% |
| 2023-12-31 | zł27.74 Million | zł-5.32 Million | -0.192x | +71.57% |
| 2022-12-31 | zł5.62 Million | zł-3.79 Million | -0.675x | -154.05% |
| 2021-12-31 | zł9.69 Million | zł-2.57 Million | -0.266x | +73.22% |
| 2020-12-31 | zł1.37 Million | zł-1.35 Million | -0.992x | -197.46% |
| 2019-12-31 | zł1.20 Million | zł-398.48K | -0.333x | -- |